375 related articles for article (PubMed ID: 32931925)
1. Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell-derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R.
Zhang XH; Wei H; Xia Y; Morad M
Heart Rhythm; 2021 Feb; 18(2):250-260. PubMed ID: 32931925
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca
Wei H; Zhang XH; Clift C; Yamaguchi N; Morad M
Cell Calcium; 2018 Jul; 73():104-111. PubMed ID: 29730419
[TBL] [Abstract][Full Text] [Related]
3. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects.
Zhang XH; Haviland S; Wei H; Sarić T; Fatima A; Hescheler J; Cleemann L; Morad M
Cell Calcium; 2013 Aug; 54(2):57-70. PubMed ID: 23684427
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 Gene Editing of RYR2 in Human iPSC-Derived Cardiomyocytes to Probe Ca
Yamaguchi N; Zhang XH; Morad M
Methods Mol Biol; 2022; 2573():41-52. PubMed ID: 36040585
[TBL] [Abstract][Full Text] [Related]
5. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O
J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920
[TBL] [Abstract][Full Text] [Related]
6. In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.
Fatima A; Xu G; Shao K; Papadopoulos S; Lehmann M; Arnáiz-Cot JJ; Rosa AO; Nguemo F; Matzkies M; Dittmann S; Stone SL; Linke M; Zechner U; Beyer V; Hennies HC; Rosenkranz S; Klauke B; Parwani AS; Haverkamp W; Pfitzer G; Farr M; Cleemann L; Morad M; Milting H; Hescheler J; Saric T
Cell Physiol Biochem; 2011; 28(4):579-92. PubMed ID: 22178870
[TBL] [Abstract][Full Text] [Related]
7. Calcium Signaling Consequences of RyR2-S4938F Mutation Expressed in Human iPSC-Derived Cardiomyocytes.
Toth N; Zhang XH; Zamaro A; Morad M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894987
[TBL] [Abstract][Full Text] [Related]
8. Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes.
Sleiman Y; Reiken S; Charrabi A; Jaffré F; Sittenfeld LR; Pasquié JL; Colombani S; Lerman BB; Chen S; Marks AR; Cheung JW; Evans T; Lacampagne A; Meli AC
Stem Cell Res Ther; 2023 Sep; 14(1):266. PubMed ID: 37740238
[TBL] [Abstract][Full Text] [Related]
9. Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.
Kujala K; Paavola J; Lahti A; Larsson K; Pekkanen-Mattila M; Viitasalo M; Lahtinen AM; Toivonen L; Kontula K; Swan H; Laine M; Silvennoinen O; Aalto-Setälä K
PLoS One; 2012; 7(9):e44660. PubMed ID: 22962621
[TBL] [Abstract][Full Text] [Related]
10. Mutation in RyR2-FKBP Binding site alters Ca
Fernández-Morales JC; Xia Y; Renzo TJ; Zhang XH; Morad M
Cell Calcium; 2022 Jan; 101():102500. PubMed ID: 34813985
[TBL] [Abstract][Full Text] [Related]
11. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.
Jung CB; Moretti A; Mederos y Schnitzler M; Iop L; Storch U; Bellin M; Dorn T; Ruppenthal S; Pfeiffer S; Goedel A; Dirschinger RJ; Seyfarth M; Lam JT; Sinnecker D; Gudermann T; Lipp P; Laugwitz KL
EMBO Mol Med; 2012 Mar; 4(3):180-91. PubMed ID: 22174035
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia.
Pan X; Philippen L; Lahiri SK; Lee C; Park SH; Word TA; Li N; Jarrett KE; Gupta R; Reynolds JO; Lin J; Bao G; Lagor WR; Wehrens XHT
Circ Res; 2018 Sep; 123(8):953-963. PubMed ID: 30355031
[TBL] [Abstract][Full Text] [Related]
13. Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential.
Stutzman MJ; Kim CSJ; Tester DJ; Hamrick SK; Dotzler SM; Giudicessi JR; Miotto MC; Gc JB; Frank J; Marks AR; Ackerman MJ
Stem Cell Reports; 2022 Sep; 17(9):2023-2036. PubMed ID: 35931078
[TBL] [Abstract][Full Text] [Related]
14. Uptake-leak balance of SR Ca
Lopez R; Janicek R; Fernandez-Tenorio M; Courtehoux M; Matas L; Gerbaud P; Gomez AM; Egger M; Niggli E
J Mol Cell Cardiol; 2022 Sep; 170():1-14. PubMed ID: 35644481
[TBL] [Abstract][Full Text] [Related]
15. Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia.
Domingo D; Neco P; Fernández-Pons E; Zissimopoulos S; Molina P; Olagüe J; Suárez-Mier MP; Lai FA; Gómez AM; Zorio E
Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):398-407. PubMed ID: 25440180
[TBL] [Abstract][Full Text] [Related]
16. Modeling polymorphic ventricular tachycardia at rest using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Sleiman Y; Souidi M; Kumar R; Yang E; Jaffré F; Zhou T; Bernardin A; Reiken S; Cazorla O; Kajava AV; Moreau A; Pasquié JL; Marks AR; Lerman BB; Chen S; Cheung JW; Evans T; Lacampagne A; Meli AC
EBioMedicine; 2020 Oct; 60():103024. PubMed ID: 32980690
[TBL] [Abstract][Full Text] [Related]
17. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models.
Penttinen K; Swan H; Vanninen S; Paavola J; Lahtinen AM; Kontula K; Aalto-Setälä K
PLoS One; 2015; 10(5):e0125366. PubMed ID: 25955245
[TBL] [Abstract][Full Text] [Related]
19. Point mutations in RyR2 Ca2+-binding residues of human cardiomyocytes cause cellular remodelling of cardiac excitation contraction-coupling.
Xia Y; Zhang XH; Yamaguchi N; Morad M
Cardiovasc Res; 2024 Feb; 120(1):44-55. PubMed ID: 37890099
[TBL] [Abstract][Full Text] [Related]
20. Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.
Manotheepan R; Danielsen TK; Sadredini M; Anderson ME; Carlson CR; Lehnart SE; Sjaastad I; Stokke MK
Cardiovasc Res; 2016 Aug; 111(3):295-306. PubMed ID: 27161030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
